caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1396087342

Beth ZhaM.D., PH.D.

Pulmonary DiseaseSan Francisco, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
744
Unique beneficiaries
—
Total services
951
Distinct HCPCS
16
Medicare payment
$44K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — above median (cohort median 927).
PRESCRIBING · PART D · 2024
Total Rx claims
1,105
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
26
Brand share
68.8%
Top prescribed drugs
Albuterol Sulfate146 claims
Umeclidinium Brm/Vilanterol Tr132 claims
Tiotropium Br/Olodaterol Hcl88 claims
Azithromycin81 claims
Tiotropium Bromide53 claims
QUALITY · MIPS · 2024
Final MIPS score
100.0
Quality
95.0
Cost
80.6
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
1.05%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$5K
Payment records
6
By payment type
Consulting Fee$5K
Food and Beverage$149